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Monoterpenoids are found in essential oils from numerous
plant families. Octopamine is a biogenic monoamine found
within various invertebrates, including insects. Octopamine
exerts its physiological effects through the activation of
G-protein-coupled receptors (GPCRs). GPCRs are an
under-utilized receptor target in the agrochemical industry.
Here we report the expression of an octopamine receptor from
the brain of the American cockroach (Periplaneta americana)
in Saccharomyces cerevisiae, creating a ligand-independent
histidine-auxotrophic assay. The majority of monoterpenoids
acted as an inverse agonist in this system. Three QSAR
models show that electronic properties are most important for
monoterpenoid interaction with this octopamine receptor in this
yeast assay.
Introduction
Concern about the adverse health and environmental effects of conventional
synthetic insecticides is evident through governmental restrictions, like the
Food Quality Protection Act of 1996, limiting the availability of traditional
synthetic insecticides. Therefore there is the need to identify safe but effective
© 2013 American Chemical Society
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compounds to control insect pests. Natural products, like essential oils and
essential oil components, are becoming a valuable source for lead compounds
for insecticide development. Essential oils have been known since the Middle
Ages for their antibacterial properties. Essential oils can be derived from multiple
tissues of plants by steam or hydro-distillation (1). Essential oils are complex
mixtures, primarily composed of terpenoids (mono- and sesquiterpenoids) at
various concentrations. The complexity of the terpenoid mixture is enhanced by
the presence of various functional groups, stereochemistry, and carbon skeletal
structures (1). The toxicity of essentials oils and their terpenoid constituents
to insects has been the focus of several studies (2–4). While these terpenoids
have been shown to be toxic to insects, their precise mechanism of how they
exert this toxic action is not fully understood. Various studies have indicated
that monoterpenoids may have several mechanisms of action. Mechanisms that
have been reported include: inhibition of acetylcholinesterase (5, 6), binding
at the GABA receptor (7–11), binding at the nicotinic acetylcholine receptor
(12), the octopamine receptor (13, 14), and the tyramine receptor (15). Previous
studies have also described quantitative structure-activity relationships (QSARs)
to describe the toxicity of monoterpenoids and their interaction at the GABA
receptor (11).
Octopamine is found in numerous invertebrates and functions as a
neurohormone, neurotransmitter, and neuromodulator. Octopamine has been
shown to have numerous physiological actions in the insects’ nervous system and
several peripheral target sites. Octopamine in insects is believed to be comparable
to norepinephrine in vertebrates. This is because of its similarities in its chemical
structure, but also its physiological action (16–18). An octopamine receptor
has previously been isolated and characterized from the American cockroach,
Periplaneta americana (Pa oa1) and was used to describe monoterpenoid
interactions here (19).
GPCRs have been studied for their possible involvement in human disease
and as targets for pharmaceutical intervention. It is estimated that 30-45% of
current pharmaceuticals target GPCRs (20). However, GPCRs have been an
under-utilized target in the agrochemical industry. Saccharomyces cerevisiae,
referred to as yeast hereafter, has emerged as an important organism for the
study of heterologously expressed GPCRs (21, 22). Functional expression of
heterotrimeric GPCRs can be achieved by linking the expressed receptor to
the endogenous pheromone response pathway, which has been performed for
analysis of multiple mammalian GPCRs (22) and some invertebrate GPCRs
(23–25). Previously, we have reported the expression of Pa oa1 in yeast,
which resulted in a ligand-independent (constitutive) expression system (25).
Constitutively expressed GPCRs can still yield important results about ligands
interacting with the expressed receptor (26, 27). For instance, constitutively
active expression of GPCRs can identify compounds that act as inverse agonists
or potentially as allosteric modulators (27). A constitutively expressed system
can show the possibility of a compound interacting with a receptor resulting
in various conformations of activation or inactivation. Here we expand on
previously screened monoterpenoids against Pa oa1 expressed in yeast to
prescribe physicochemical properties that are important for this interaction.
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Materials and Methods
Insects
American cockroaches (P. americana) were maintained in an established
colony on a 14:10 light:dark photocycle at 23 ± 2°C. These insects were provided
with an unlimited supply of dry cat food and water.
Chemicals
All monoterpenoids and related aromatic compounds were purchased from
Sigma (St. Louis, MO) with the exception of pulegone, which was purchased from
Eastman Chemical Company (Miami, FL). For screening purposes the compounds
were dissolved in certified dimethyl sulfoxide (DMSO) and serially diluted to a
screening concentration of 1 x 10-4 M. The final concentration of DMSO to which
the cells were exposed was less than 1%.
Isolation and Functional Expression of Pa oa1
The isolation and expression of the American cockroach octopamine
receptor Pa oa1, was performed as previously described (25). Briefly, RNA
was extracted from adult American cockroaches. cDNA was prepared with
gene-specific primers based on the previous sequence of Pa oa1 (19). NcoI and
XbaI restriction sites were added to the Pa oa1 open reading frame and amplified.
Amplicons were ligated into the yeast expression vector, Cp4258. Yeast cells
were transformed using a lithium acetate method. Specifically, yeast cell line CY
14083 (genotype: MATα PFUS1-HIS3 GPA1-Gαo(5) can1 far1Δ1442 his3 leu2
lys2 sst2Δ2 ste14::trp1::LYS2 ste18γ6-3841 Ste3Δ1156 tbt1-1 trp1 ura3) was
transformed with Cp4258 carrying the Pa oa1 open reading frame (yeast cells
were kindly provided by J. Broach, Princeton University). Comparisons were
made to mock-transfected yeast cells that had the expression vector, Cp4258,
but lacking Pa oa1. Cp4258 contains a constitutively active leucine gene, which
allows for selection of yeast cells transformed with the appropriate vector.
Histidine-Auxotrophic Assay
The histidine-auxotrophic assay is the expression of Pa oa1, or an exogenous
GPCR, which couples to the yeast’s endogenous pheromone-response pathway
(the yeast’s reproductive system). This is a modified auxotorophic yeast strain,
which carries aHis3 reporter gene under transcriptional control of the pheromone-
responsive Fus1 promoter. His3 expression results in the synthesis of histidine.
Therefore, when the receptor is in the active state, histidine will be produced,
and yeast cells will grow when they are present in histidine-deficient medium.
The histidine-auxotrophic assay was performed similarly to previous reports from
our laboratories (23, 25).Briefly, 2 mL of selective medium (-Leu) was inoculated
with transformed yeast cells and allowed to grow overnight on an orbital shaker
(30°C and 250 RPM (OD600 1.0-2.0)). Cells were pelleted at 5,000 x g at room
temperature and washed three times with medium which was deficient in leucine
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and histidine. The pellet was resuspended in 1 mL of leucine/histidine-deficient
media supplemented with 10 mM 3-amino-1,2,4-triazole (3-AT;Sigma) to help
control growth by interfering with histidine synthesis. Cells were dispensed into a
96-well clear Costar® plate with a total volume of 200 μL at 15-20 cells/μL (OD600
of 0.01), which included 10 μL of vehicle or test compound solution. Cells were
allowed to grow at 30°C and 98% humidity for 24 hr at which time optical density
readings (absorbance of 600 nm) were taken using a Spectramax 190 (Molecular
Devices, Inc. Sunnyvale, CA). Experiments were performed in quadruplicate on
96-well plates for one experiment, with a total of five experiments performed for
statistical analysis.
Figure 1. This figure shows numbering of the aromatic monoterpenoids used in
the yeast assay and used for Model 1.
QSAR Calculations and Analysis
Descriptors were chosen to measure classical and semi-empirical quantum
parameters. Descriptors included the water-octanol partition coefficient (Log P),
lowest unoccupied molecular orbital (LUMO), highest occupied molecular orbital
(HOMO), dipole moment, Mulliken charge, Lwdin charge, and polarizability.
Calculations were performed using GAMESS interfaced with ChemBio3D
Ultra 12. (Cambridge Software Corporation, Cambridge MA). The energy and
geometry of candidate monoterpenoids were optimized and analyzed using a
split valence basis set and a polarization function (6-31*d). Electrotopological
state of candidate monoterpenoids was calculated with E-Calc (Scivision
INC., Burlington, MA). Prior to calculation of selected descriptors, six of the
monoterpenoid carbons were numbered, and this was focused on a six-member
ring (Figure 1 and Figure 2). In aromatic monoterpenoids, the six carbons of
the aromatic ring were numbered (Figure 1). In acyclic monoterpenoids, carbon
skeleton structures were drawn in a conformation that gave a structure similar
to cyclic monoterpenoids, and carbons were numbered 1-6 (Figure 2). Carbon
numbering was based on substituents. For monoterpenoids that did not contain a
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heteroatom (oxygen), the lowest number was assigned to the largest substituent
(i.e. propyl versus methyl). The next lowest number was given to the carbon
bonded to the next closest substituent; priority was always given to the next
largest substituent, if applicable. A monoterpenoid that contained a heteroatom
that was directly attached to one of the six numbered carbon atoms was given
a lower number than a heteroatom attached to a carbon that was not directly
numbered 1-6 (carbonyl). In compounds that contained two heteroatoms, a lower
number was given to a hydroxyl versus an ether.
Figure 2. This figure shows the numbering of the aliphatic acyclic, cyclic, and
bicyclic monoterpenoids used in this assay to produce Model 2 and Model 3.
Selected descriptors and the growth results, log transformed, from the ligand-
independent yeast histidine-auxotrophic assay were analyzed with simple linear
and multiple linear regressions. The square of the correlation coefficient (R2) of
≥ 0.8 was required to describe activity. Regression models were validated using
the leave-one-out method (Q2), shown in the equation below. Simple and multiple
linear regression models that had an R2 of ≥ 0.8 and a Q2 of ≥ 0.6 were suggested
to have a non-random relationship (28).
where,
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Statistical Analysis
Statistical analysis of data obtained from the yeast growth assay was obtained
using Analysis of Variance (ANOVA) with α=0.05, using SAS 9.2 (SAS Institute
Inc., Cary, NC). Yeast growth was normalized with respect to the vehicle control,
and log transformations were performed to achieve an accurate fit model. Linear
and multiple regression models were obtained with SAS 9.2.
Results
Yeast Histidine-Auxotrophic Assay
Monoterpenoid activity at Pa oa1 was determined using a histidine-
auxotrophic yeast functional expression assay. However, expression of Pa oa1
in a modified auxotrophic yeast strain CY 14083 resulted in a 35-fold increase
in growth over yeast cells not expressing Pa oa1 (25). When cells expressing Pa
oa1 were exposed to octopamine and its immediate synthetic precursor, tyramine,
there was not a significant result from the vehicle (Table 1). However, three
octopaminergic compounds, phentolamine, synephrine, and chlordimeform,
resulted in decreases in yeast growth (Table 1).
Table 1. The effect of octopaminergic compounds on yeast growth by using
a yeast expression of a heterologous Pa oa1. Growth that was significantly
affected is shown in bold with an asterisk (ANOVA, α = 0.05).
Octopaminergics
Compound % Yeast growth ± SEM
Vehicle (control) 100%
Octopamine 99 ± 2%
Tyramine 96 ± 4%
Phentolamine 63 ± 2% *
Synephrine 65 ± 3% *
Chlordimeform 76 ± 2% *
The expressed Pa oa1 was screened against 21 monoterpenoids with various
effects on its activity (Table 2 and Table 3). In the ligand-independent system, all
of the aliphatic and most of the aromatic monoterpenoids acted as inverse agonists.
Only one of the tested monoterpenoids, carvacrol, resulted in an increase in yeast
growth (Table 2).
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Table 2. The effect of aromatic monoterpenoids on yeast growth by using
a yeast expression of a heterologous Pa oa1. Growth that was significantly
affected is shown in bold with an asterisk (ANOVA, α = 0.05).
Aromatic
Monoterpenoids
Compound % Yeast growth ± SEM
vehicle (control) 100%
carvacrol 130 ± 7%*
Thymol 103 ± 2%
Safrole 93 ± 3%*
Cymene 80 ± 3%*
phenethyl propionate 80 ± 4%*
cinnamic acid 65 ± 4%*
Eugenol 30 ± 2%*
Methyl eugenol 17 ± 10%*
Figure 3. This figure shows the observed log of yeast growth versus the calculated
log of yeast growth for the aromatic monoterpenoids. It resulted in Model 1: Y =
1.55(±0.23) + 7.56 (±1.00) [MCC3] + 0.72 (±0.24) [MCC1] – 0.12 (±0.02)[DM]
with an R2 = 0.9109, F=20.45, and a Q2 = 0.8582.
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QSAR Analysis and Models
The biological data along with the output calculations of physicochemical
properties allowed for simple and multiple linear regressions to be performed.
Initially, all screened terpenoids (aromatic, cyclic, acyclic, and bicyclic) were
placed in the same training set; however, it did not result in an R2 >0.8 or Q2 >0.6,
which were the preset guidelines. Therefore, an aromatic monoterpenoid (Figure
1) training set was used to identify a model that predicts growth activity as a result
of aromatic monoterpenoids interacting with the expressed Pa oa1. A multiple
linear regression model (Model 1), within the identified limits (R2 ≥ 0.8 and Q2 ≥
0.6), for 10 aromatic monoterpenoids (Figure 1) was determined (Model 1, Figure
3, Table 4). Model 1 resulted in an R2 of 0.9109, F=20.45, and a Q2 of 0.8582.
Model 1 shows that an increase in theMulliken charge at carbon-3 (MCC3) and the
Mulliken charge at carbon-1 (MCC1) (indicating an increase in electron density at
these two carbons) cause a greater interaction with expressed Pa oa1. Furthermore,
a decrease in the dipole moment (DM) of the aromatic monoterpenoids is also
important to the interaction of aromatic monoterpenoids with expressed Pa oa1.
Table 3. The effect of aliphatic monoterpenoids on yeast growth by using
a yeast expression of a heterologous Pa oa1. Growth that was significantly
affected is shown in bold with an asterisk (ANOVA, α = 0.05).
Aliphatic
Monoterpenoids
Compound % Yeast growth ± SEM
vehicle (control) 100%
limonene oxide 99 ± 3%
α-terpineol 92 ± 5%
linalool 91 ± 2%
1,8-cineole 89 ± 5%
1,4-cineole 78 ± 6%*
citronellic acid 74 ± 4%*
pulegone 73 ± 2%*
limonene 68 ± 5%*
camphor 56 ± 4%*
Data from the 11 aliphatic monoterpenoids (Figure 2) resulted in a multiple
linear regression model (Model 2 Figure 4, Table 5). This multiple linear
regression model was within the identified model limits (R2 ≥ 0.8 and Q2 ≥ 0.6)
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for all of the aliphatic compounds. Model 2 resulted in an R2 = 0.8175, F = 5.60,
and Q2 = 0.6358. This model shows that a decrease in the Mulliken charge around
carbon-1 (MCC1) with an increase in the Lwdin charge at carbon-1 (LCC1), an
increase in the HOMO, and the electrotopological state at carbon-6 (ES6) are
important factors in aliphatic monoterpenoids interacting with Pa oa1 and thereby
affecting the growth of the yeast cells. While Model 2 fits within the parameters
initially identified, removal of the four bicyclic aliphatic monoterpenoids resulted
in a model with a higher R2 and Q2 (Model 3 Figure 5, Table 6).
Table 4. This table shows the values for the observed and predicted yeast
growth to form Model 1. It also shows the residual for the observed and
predicted yeast growth.
Aromatic monoterpenoid
Observed
yeast growth
Predicted yeast
growth Residual
carvacrol 0.11 0.13 0.02
thymol 0.01 0.04 0.03
cinamic acid -0.19 -0.18 0.01
cymene -0.10 -0.13 0.03
eugenol -0.52 -0.70 0.18
methyl-eugenol -0.77 -0.46 0.31
phenethyl propionate -0.18 -0.12 0.06
piperonal -0.27 -0.21 0.06
safrole -0.10 -0.25 0.15
vanillin -0.51 -0.66 0.15
Model 3 is produced by reducing the training set from 11 to seven aliphatic
monoterpenoids, which increased the R2, Q2, and F-value to 0.9211, 0.8716, and
29.94, respectively. Model 3 shows that a decrease in the Lwdin charge at carbon-3
(LCC3), along with an increase of the Mulliken charge at carbon-4 (MCC4) and
an increase in the electrotopological state at carbon-3 (ES3) causes an increase
the growth of yeast, presumably by the monoterpenoid interaction with Pa oa1.
Again, this is showing the electron density around certain carbons to be important
in describing the interaction of the aliphatic monoterpenoids with Pa oa1.
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Figure 4. This figure shows observed log of yeast growth versus calculated
log of yeast growth for all aliphatic monoterpenoids. This was used to form
Model 2: Y = 1.10 (±0.56) – 1.52 (±0.39)[MCC1] + 1.57 (0.54)[LCC1] +
0.08(±0.04)[HOMO] + 0.08 (±0.03)[ES6] with an R2=0.8175, F = 5.60, and
Q2 =0.6358.
Table 5. This table shows the values for the observed and predicted yeast
growth to form Model 2. It also shows the residual for the observed and
predicted yeast growth.
Aromatic
monoterpenoid
Observed
yeast growth
Predicted
yeast
growth Residual
1,8-cineol -0.05 -0.06 0.01
1,4-cineol -0.11 -0.05 0.06
α-terpineol -0.04 0.02 0.06
α-pinene 0.00 -0.10 0.10
camphor -0.26 -0.31 0.05
limonene -0.17 -0.02 0.14
Continued on next page.
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Table 5. (Continued). This table shows the values for the observed and
predicted yeast growth to form Model 2. It also shows the residual for the
observed and predicted yeast growth.
Aromatic
monoterpenoid
Observed
yeast growth
Predicted
yeast
growth Residual
limonene oxide -0.01 -0.09 0.08
menthol -0.09 -0.12 0.04
pulegone -0.14 -0.08 0.06
linalool -0.04 -0.04 0.01
Figure 5. This figure shows observed log of yeast growth versus calculated log of
yeast growth for acyclic and cyclic aliphatic monoterpenoids. This was used to
form Model 3: Y = -5.41(±0.73) – 20.30(±2.71)[LCC3] + 2.01(±0.31)[MCC4] +
0.16(±0.04)[ES3] with an R2 =0.9211, F-value 29.94 , and Q2=0.8716.
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Table 6. This table shows the values for the observed and predicted yeast
growth to form Model 3. It also shows the residual for the observed and
predicted yeast growth.
Aliphatic
monoterpenoid
Observed
yeast
growth
Predicted
growth
yeast Residual
α-terpineol -0.04 -0.02 0.01
limonene -0.17 -0.13 0.03
limonene oxide -0.01 0.00 0.01
menthol -0.09 -0.07 0.02
pulegone -0.14 -0.21 0.07
linalool -0.04 -0.07 0.03
Discussion
The expression of Pa oa1 in yeast resulted in a ligand-independent
expression system; the lack of response to the previously identified ligand,
octopamine, suggests that the receptor is fully activated (Table 1). However, other
octopaminergic compounds interacted with the Pa oa1, which is constitutively
active, and decrease the response of this receptor in this system. This probably is
not related to the in vivo function of these ligands but shows an interaction with
Pa oa1 (Table 1). Several octopaminergic compounds and monoterpenoids were
shown to interact with the octopamine receptor, significantly altering the growth
rate of yeast cells. It has been previously suggested that a ligand-independent
screening system is beneficial in identifying molecules that can block this
activity. Further, this type of assay is advantageous in the detection of compounds
that can regulate the function of Pa oa1 independent of its ligand, octopamine
(27). Previously, several constitutively active human GPCRs, formed by
over-expression in Xenopus laevismelanophores, were used to search for potential
new drugs (26).
In this study, octopaminergic compounds were shown to affect the growth of
yeast by interacting with Pa oa1. In a ligand-independent system octopaminergic
compounds acted as inverse agonists. Therefore, octopaminergic compounds
are interacting in some manner with Pa oa1 that changes the conformation
of the receptor, decreasing the affinity for the endogenous G-protein, thereby
decreasing the signaling through the endogenous pheromone response pathway
and decreasing the production of histidine and therefore decreasing yeast cell
growth. However, one of the monoterpenoids tested, carvacrol, was shown to
increase growth of the yeast cells (Figure 2). This suggests that this aromatic
monoterpenoid interacts with Pa oa1 altering the conformation of the receptor
and increasing the affinity for the endogenous G-protein. This increases the
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production of histidine and therefore an increase in yeast cell growth. The current
system provides a response that can be characterized as interacting with Pa oa1
at various degrees of efficacy (at one concentration). Therefore, we suggest
that this assay is good for providing an initial indication of the interaction of a
monoterpenoid with the receptor, but further analysis should be performed to
determine the exact efficacy.
Twenty-one monoterpenoids were tested in this study and used to create
models to predict activity at a constitutively active Pa oa1 receptor. It has
previously been suggested that octopamine receptor activity is enhanced with the
presence of an oxygen atom (13). However, p-cymene, which lacks an oxygen
substituent, showed a significant result in our assay, but was not as effective as
other monoterpenoids that contained an oxygen substituent. Methyl-eugenol
showed the best response in this assay. Methyl-eugenol contains a hydroxyl and
ether directly attached to the aromatic ring. In contrast, the bicyclic aliphatic
monoterpenoid, camphor, which contains a ketone, was the most active aliphatic
monoterpenoid tested. Limonene was the next best aliphatic monoterpenoid and
does not contain an oxygen substituent; this again shows that an oxygen atom was
not necessary for activity in this system.
Various structural features of the tested monoterpenoids were quantified
using physicochemical properties. This resulted in the formation of three models
to describe the activity of monoterpenoids at the ligand-independent octopamine
receptor (Pa oa1). It was evident that electronic parameters are important in
prescribing this interaction. Electronic parameters were also important in QSAR
models using similar compounds at the insect GABA receptor (11). In the
training set composed of all aromatic monoterpenoids: as the electronic density
at carbon-3 and carbon-1 increased, a compound’s interafction with Pa oa1
also increased (a decrease or increase in growth). A decrease in the molecule’s
dipole moment also increased aromatic monoterpenoids’ interaction with Pa oa1.
Electronic parameters were demonstrated to be important in acyclic, cyclic, and
bicyclic aliphatic monoterpenoids with increases in the HOMO and increases
in the electronic accessibility (E-state) at carbon-6 causing greater interaction
with Pa oa1. However, removing bicyclic aliphatic monoterpenoids from Model
2 resulted in a better model (Model 3). In Model 3, electronic parameters at
carbons 3 and 4 were important in the interaction of acyclic and cyclic aliphatic
monoterpenoids.
Conclusion
Electronic parameters are important in determining the effect of various
monoterpenoids’ activities at the octopamine receptor. Decreasing the aliphatic
training set to exclude bicyclic monoterpenoids increased the quality of the model
but limited the size of the training set. Future studies should focus on increasing
the number of molecules within a training set to get more comprehensive models.
This may include the introduction of synthetic derivatives of naturally occurring
monoterpenoids. Expression of Pa oa1 in a mammalian-based cell system also
may result in a more effective testing plateform.
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